We are Sorry, This Page doesn't Exist
Why Patterson-UTI Energy"s Stock Is Trading Lower Today
Paterson-Uti Energy (NASDAQ: PTEN) shares were trading lower on Thursday after the company reported fourth-quarter results. While the company beat estimates, EPS and sales fell year over year. read more.....»»
Why These 4 Health Care Stocks Are Moving Today
Osmotica Pharmaceuticals (NASDAQ: OSMT) shares were trading higher Monday in anticipation of a ruling by the FDA on the company's New Drug Application for Arbaclofen ER in patients with multiple sclerosis. read more.....»»
Why Vertex"s Stock Is Trading Higher Today
Vertex Pharmaceuticals (NASDAQ: VRTX) shares are trading higher after Argus Research maintained a Buy rating on the stock and raised its price.....»»
Titan Pharmaceuticals Reports First Quarter 2020 Financial Results
SOUTH SAN FRANCISCO, Calif., May 15, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ("Titan" or the "Company") today reported finan.....»»
ABC’s Construction Backlog Indicator falls in April; Contractor Confidence rebounds from historic lows
Associated Builders and Contractors reported today that its Construction Backlog Indicator fell to 7.8 months in April, the series’ lowest reading since.....»»
Bitcoin, Ethereum & Ripple - American Wrap: 5/11/2020
Bitcoin Price Analysis: BTC/USD Just Dumped Another $300+ The price has been very choppy today as the chart below shows. There has been a pullback, but as soon as the price hit 9182.66, the market turned and fell in two stages. read more.....»»
Corbus Pharmaceuticals: Q1 Earnings Insights
Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) fell 1.3% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per sha.....»»
Corbus Pharmaceuticals: Q1 Earnings Insights
Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) fell 1.3% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were flat 0.00% year over year to ($0.43), which missed the estimate of ($0.40). read more.....»»
Recap: BioCryst Pharmaceuticals Q1 Earnings
Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) fell 2% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 14.29% over the past year to ($0.24), which beat the estimate of ($0.25). read more.....»»
Why Alexion"s Stock Is Trading Lower Today
Alexion Pharmaceuticals (NASDAQ: ALXN) shares are trading lower on Tuesday, after the company reported the purchase of Portola Pharma for $18 per read more.....»»
Conatus Pharmaceuticals Reports First Quarter 2020 Financial Results and Strategic Process Update
SAN DIEGO, May 01, 2020 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) today announced f.....»»
Idera Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
EXTON, Pa., April 30, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. ("Idera" or the "Company") (NASDAQ:IDRA) today reported its.....»»
Mid-Day Market Update: NASDAQ Turns Negative; Syndax Pharmaceuticals Shares Jump
Midway through trading Tuesday, the Dow traded up 0.14% to 24167.41 while the NASDAQ fell 0.8% to 8662.89. The S&P also fell, dropping 0.02% to 2,877.81. read more.....»»
Mid-Day Market Update: NASDAQ Turns Negative; Syndax Pharmaceuticals Shares Jump
Midway through trading Tuesday, the Dow traded up 0.14% to 24167.41 while the NASDAQ fell 0.8% to 8662.89. The S&P al.....»»
Benzinga Pro"s Top 5 Stocks To Watch For Fri., Apr. 24, 2020: GILD, DKNG, FFIV, ADC, SGMS
Today's 5 Stock Ideas:Â Gilead (GILD)Â - One of the most important stocks on Wall Street right now. Shares fell sharply Thursday (bringing down the entire stock market too) after a report suggested a read more.....»»
Mid-Day Market Update: TriState Capital Jumps Following Q1 Results; Cyclacel Pharmaceuticals Shares Plunge
Midway through trading Tuesday, the Dow traded down 2.88% to 22968.65 while the NASDAQ fell 3.94% to 8223.52......»»
Why Alexion"s Stock Is Trading Higher Today
Alexion Pharmaceuticals (NASDAQ: ALXN) shares are trading higher on Monday. The company announced plans to initiate Phase 3 study of ULTOMIRIS in hospitalized patients with severe COVID-19. read more.....»»
Mid-Afternoon Market Update: Dow Falls Over 400 Points; NovaBay Pharmaceuticals Shares Jump
Toward the end of trading Monday, the Dow traded down 1.79% to 23807.82 while the NASDAQ fell 0.49% to 8607.34. The S&P also fell, dropping 1.28% to 2837.73. read more.....»»
Mid-Day Market Update: Crude Oil Plunges 45%; Cyclacel Pharmaceuticals Shares Jump
Midway through trading Monday, the Dow traded down 0.71% to 24,070.23 while the NASDAQ rose 0.35% to 8,680.06. The S&P also fell, dropping 0.28% to 2,866.43. read more.....»»
Morgan Stanley Misses On EPS, But Shows Strong Trading Results For Q1 As Banks Wrap Up
Any rally today will have a fight on its hands against a cascade of fresh dismal data. Initial jobless claims of 5.2 million last week came in a little worse than analysts had expected, and housing starts fell out of bed in March with a 22.3% decline. .....»»